Computer-aided detection (CAD) developer Confirma of Bellevue, WA, has installed its CADstream for prostate software at four research sites, including Beth Israel Hospital in Boston and the Lahey Clinic in Burlington, MA.
The research sites are assisting Confirma in the development and commercialization of CADstream for prostate imaging using MRI. The prostate application is designed to offer physicians clinically valuable tools for improved quality, standardization, and efficiency in MRI prostate studies.
Except for skin cancer, prostate cancer is the most common malignancy in American men.
By AuntMinnie.com staff writers
October 2, 2007
Related Reading
Confirma to launch breast MRI CME program, August 16, 2007
Confirma taps CFO, July 2, 2007
Confirma appoints Sparacio as VP of sales, June 19, 2007
Confirma, Guardian partner on CAD, April 26, 2007
Kodak, Confirma ink deal, January 17, 2007
Copyright © 2007 AuntMinnie.com
